2013 PSRGN Conference Agenda
New Song Facility, Irvine, CA.
7:30 - 8:30am
8:30 - 8:35a
Registration/check-in and continental breakfast (provided)
Welcome and Orientation
8:35 – 9:25a Troubleshooting, Thinking Outside the Box
Robin Vandergon, M.A.; CG(ASCP)CM, DLM(ASCP)CM Fresno, CA
9:25- 10:15a Oncogene Amplification as an Incidental Finding in FISH Testing for
Lymphoid Hematopoietic Neoplasms
Guoxian Sun, M.D., FACMG; Clinical Cytogenetics, Clarient/GE Healthcare, Aliso Viejo, CA
10:15-10:35a Refreshment Break and Vendor Interaction.
10:35-11:30a ISCN 2013
S. Zneimer, Ph.D., FACMG; Director, Cytogenetics Laboratory, Integrated Oncology, Irvine, CA.
11:30-12:00
Pick up Lunch (provided), Vendor Interaction.
12:00-12:55p Case Study Presentations
Robin Vandergon, M.A.; CG(ASCP)CM, DLM(ASCP)CM
12:55-1:05p
Short break post lunch cleanup.
1:05 – 1:55
Translational Science, Clinical Medicine and Personal Genomes
K. D. Becker, Ph.D.; Chief Scientific Officer, Pathway Genomics Corporation, San Diego, CA.
1:55 - 2:45p
AML Diagnosis, Prognosis, and Progression: Biomarkers as the Key
Amy E. Hanlon Newell, Ph.D. Manager, Scientific Affairs, Research and Development, Abbott Molecular Inc.
Des Plaines, IL
2:45 - 3:05p
3:05 - 3:55p
Break (snack and beverage provided); Vendor Interaction.
Application of Cytogenetics to Endangered Species Conservation
M. L. Houck, CG(ASCP)CM; Associate Researcher, Zoological Society of San Diego, Conservation and
Research for Endangered Species, San Diego, CA.
3:55 - 4:45p
FISH and Molecular Testing Strategies in Lung Cancer.
Robert Gasparini, MS: Director & Chief Scientific Officer, NeoGenomics Laboratories, Fort Myers, FL
4:45 – 4:50p Concluding Remarks, Evaluation, Adjournment
Credit will be given for 8 Contact Hours